SK284092B6 - Pevná dávkovacia forma na cmúľanie, ktorá obsahuje flurbiprofen, na liečenie bolesti v krku a jej použitie - Google Patents

Pevná dávkovacia forma na cmúľanie, ktorá obsahuje flurbiprofen, na liečenie bolesti v krku a jej použitie Download PDF

Info

Publication number
SK284092B6
SK284092B6 SK665-98A SK66598A SK284092B6 SK 284092 B6 SK284092 B6 SK 284092B6 SK 66598 A SK66598 A SK 66598A SK 284092 B6 SK284092 B6 SK 284092B6
Authority
SK
Slovakia
Prior art keywords
flurbiprofen
dosage form
sugar
patient
sore throat
Prior art date
Application number
SK665-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK66598A3 (en
Inventor
David Michael Barrett
Carl Simon Smith
David Michael Thurgood
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of SK66598A3 publication Critical patent/SK66598A3/sk
Publication of SK284092B6 publication Critical patent/SK284092B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
SK665-98A 1995-11-22 1996-11-21 Pevná dávkovacia forma na cmúľanie, ktorá obsahuje flurbiprofen, na liečenie bolesti v krku a jej použitie SK284092B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (2)

Publication Number Publication Date
SK66598A3 SK66598A3 (en) 1998-12-02
SK284092B6 true SK284092B6 (sk) 2004-09-08

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
SK665-98A SK284092B6 (sk) 1995-11-22 1996-11-21 Pevná dávkovacia forma na cmúľanie, ktorá obsahuje flurbiprofen, na liečenie bolesti v krku a jej použitie

Country Status (21)

Country Link
US (2) US5889057A (ru)
EP (1) EP0862424B1 (ru)
CN (1) CN1148177C (ru)
AT (1) ATE252382T1 (ru)
AU (1) AU707749B2 (ru)
BG (1) BG64166B1 (ru)
CA (1) CA2238271C (ru)
CZ (1) CZ289643B6 (ru)
DE (1) DE69630460T2 (ru)
DK (1) DK0862424T3 (ru)
ES (1) ES2208768T3 (ru)
GB (1) GB9523833D0 (ru)
HU (1) HU225235B1 (ru)
IL (1) IL124568A0 (ru)
NO (1) NO317287B1 (ru)
NZ (1) NZ322933A (ru)
PT (1) PT862424E (ru)
RU (1) RU2203655C2 (ru)
SK (1) SK284092B6 (ru)
UA (1) UA46807C2 (ru)
WO (1) WO1997018802A1 (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CA2374003C (en) * 1999-05-17 2008-02-12 Aesgen, Inc. Improved cellular uptake of bioactive agents
EP1284729A4 (en) * 2000-04-13 2007-12-19 Mayo Foundation REDUCTION AGENTS OF A (BETA) 42
ES2297032T3 (es) * 2001-11-13 2008-05-01 Pharmacia Corporation Forma de dosificacion oral de parecoxib.
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ES2405287T3 (es) * 2002-08-01 2013-05-30 Eisai Inc. Tratamiento mejorado del cáncer con glutamina
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
EA200800360A1 (ru) * 2005-07-22 2008-06-30 Мириад Дженетикс, Инк. Формуляции с высоким содержанием лекарства и дозированные формы
CN103622926A (zh) * 2005-11-02 2014-03-12 帝国制药美国公司 感官上可接受的布洛芬口服给药制剂、制备和使用它的方法
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
AU2008279414A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
AU2010250766B2 (en) 2009-05-19 2015-04-09 Neuroderm Ltd Compositions for continuous administration of dopa decarboxylase inhibitors
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
PT2640358T (pt) * 2010-11-15 2018-02-23 Neuroderm Ltd Administração contínua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
CN104349768B (zh) 2012-06-05 2017-11-07 纽罗德姆有限公司 包含阿朴吗啡和有机酸的组合物及其用途
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
HRP20231716T1 (hr) 2014-03-13 2024-03-15 Neuroderm Ltd. Pripravci inhibitora dopa dekarboksilaze
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
CN115536525B (zh) * 2022-09-23 2024-02-23 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
EP0228223A3 (en) * 1985-12-16 1987-09-09 Cilag AG Non-irritating suprofen solution
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
CA2064722C (en) * 1989-08-17 2001-05-08 William J. Wechter Buccal composition containing s(+) flurbiprofen or ketoprofen
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
WO1994013280A1 (en) * 1992-12-04 1994-06-23 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
CA2151912A1 (en) * 1992-12-21 1994-07-07 Richard Wilfred D'souza Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
KR970705390A (ko) * 1994-09-02 1997-10-09 리차드 시 프란슨 비마약성 진통제(non-narcotic analgesic) 및 진통효과 향상제(analgesia enhancer)를 포함하는 통증 완화 조성물(COMPOSITION ALLEVIATING PAIN, CONTAINING A NON-NARCOTIC ANALGESIC AND AN ANALGESIA ENHANCER)
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
EP0837862A1 (en) * 1995-07-05 1998-04-29 The Procter & Gamble Company Warming compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO1997038662A2 (en) * 1996-04-12 1997-10-23 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule

Also Published As

Publication number Publication date
SK66598A3 (en) 1998-12-02
BG64166B1 (bg) 2004-03-31
ATE252382T1 (de) 2003-11-15
AU2611997A (en) 1997-06-11
BG102526A (en) 1999-02-26
GB9523833D0 (en) 1996-01-24
NO317287B1 (no) 2004-10-04
EP0862424B1 (en) 2003-10-22
HUP0000180A2 (hu) 2000-08-28
CA2238271A1 (en) 1997-05-29
RU2203655C2 (ru) 2003-05-10
CA2238271C (en) 2008-08-12
CZ289643B6 (cs) 2002-03-13
DE69630460T2 (de) 2004-08-19
DE69630460D1 (de) 2003-11-27
CN1148177C (zh) 2004-05-05
CN1207677A (zh) 1999-02-10
PT862424E (pt) 2004-02-27
NO982294L (no) 1998-07-20
ES2208768T3 (es) 2004-06-16
UA46807C2 (uk) 2002-06-17
HUP0000180A3 (en) 2001-10-29
US6166083A (en) 2000-12-26
NO982294D0 (no) 1998-05-20
CZ156598A3 (cs) 1998-08-12
US5889057A (en) 1999-03-30
HU225235B1 (en) 2006-08-28
IL124568A0 (en) 1998-12-06
WO1997018802A1 (en) 1997-05-29
EP0862424A1 (en) 1998-09-09
AU707749B2 (en) 1999-07-22
DK0862424T3 (da) 2003-12-29
NZ322933A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
SK284092B6 (sk) Pevná dávkovacia forma na cmúľanie, ktorá obsahuje flurbiprofen, na liečenie bolesti v krku a jej použitie
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
RU2203046C2 (ru) Способ изготовления таблеток флурбипрофена
US20160067233A1 (en) Methods and compositions for decreasing saliva production
WO2008131340A1 (en) Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
CZ20021901A3 (cs) Farmaceutické prostředky obsahující zolmitriptan
WO2000056344A1 (fr) Salive artificielle
US5286490A (en) Transdermal fluoride medication
JP2000063268A (ja) 口腔粘膜付着型徐放性錠剤及び歯周疾患治療剤
JP5435659B2 (ja) トリプタンの経口腔粘膜投与用製剤形態
KR20150048890A (ko) 플루르비프로펜을 포함하는 약학적 조성물
US20180228832A1 (en) Stomatological composition containing nsaid or heparin compound
JPH0761933B2 (ja) 口腔用組成物
US5874065A (en) Oral anti-acid paste and methods of use
CN106822158B (zh) 红景天苷用于防治阻塞性睡眠呼吸暂停诱导型高血压
US4701467A (en) Tolrestat as anti-hypertensive agent
US4716177A (en) Tolrestat for inhibition of weight gain
JPWO2005058878A1 (ja) 月経困難症の予防および／または治療剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20141121